COPD Trial, Recruiting NCT07462221 Sponsor: Çanakkale Onsekiz Mart University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT07462221
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must have been diagnosed with COPD (a lung condition) for at least 6 months.
  • You must be currently receiving treatment as an inpatient in an internal medicine or surgical ward.
  • You must be willing to sign a consent form agreeing to take part in the study.
  • You must have access to the internet and a smartphone that runs Android or iOS.
  • You must be able to use a mobile phone.
  • You must be 40 years old or older.
  • You must be able to communicate without significant barriers (such as severe hearing or speech difficulties).
  • Your COPD must be classified as mild, moderate, severe, or very severe according to standard COPD guidelines (confirm with trial site).

Who may not be able to join:

  • You have been diagnosed with COPD less than 6 months ago.
  • You are receiving treatment as an outpatient (i.e., not staying in hospital).
  • You are currently being treated in an intensive care unit (ICU).
  • You do not have access to the internet or a smartphone with Android or iOS.
  • You are unable to use a mobile phone.
  • You are under 40 years of age.
  • You have significant communication barriers that would prevent participation.
  • You decide at any point during the study that you wish to withdraw from taking part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: SEVDA ATEŞ, Associate Professor, Çanakkale Onsekiz Mart University

Phone: 0905536088072

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Çanakkale Onsekiz Mart University
Registry
ClinicalTrials.gov
Start date
4 March 2026
Est. completion
4 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

oral healt; Quality of Life Related to Oral Health

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov